JP2025511131A5 - - Google Patents
Info
- Publication number
- JP2025511131A5 JP2025511131A5 JP2024557929A JP2024557929A JP2025511131A5 JP 2025511131 A5 JP2025511131 A5 JP 2025511131A5 JP 2024557929 A JP2024557929 A JP 2024557929A JP 2024557929 A JP2024557929 A JP 2024557929A JP 2025511131 A5 JP2025511131 A5 JP 2025511131A5
- Authority
- JP
- Japan
- Prior art keywords
- alcohol
- composition
- composition according
- bacillus
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2204716.1 | 2022-03-31 | ||
| GB2204716.1A GB2617183B (en) | 2022-03-31 | 2022-03-31 | Alcohol degrading compositions and uses thereof |
| PCT/EP2023/058370 WO2023187097A1 (en) | 2022-03-31 | 2023-03-30 | Alcohol degrading compositions and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025511131A JP2025511131A (ja) | 2025-04-15 |
| JP2025511131A5 true JP2025511131A5 (https=) | 2026-03-27 |
Family
ID=81581547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557929A Pending JP2025511131A (ja) | 2022-03-31 | 2023-03-30 | アルコール分解組成物及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250213626A1 (https=) |
| EP (1) | EP4499048A1 (https=) |
| JP (1) | JP2025511131A (https=) |
| KR (1) | KR20240167863A (https=) |
| CN (1) | CN119343134A (https=) |
| AU (1) | AU2023246874A1 (https=) |
| CA (1) | CA3246845A1 (https=) |
| GB (1) | GB2617183B (https=) |
| WO (1) | WO2023187097A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2621976B (en) * | 2022-08-19 | 2024-11-20 | De Faire Medical Ab | Compositions for use in treating and/or preventing type 2 diabetes, pre-diabetes, and/or a symptom thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH069474B2 (ja) * | 1990-03-20 | 1994-02-09 | 有限会社ビセイケン | アルコール耐性付与醗酵物の製造方法及びアルコール耐性付与醗酵食品 |
| JP4854841B2 (ja) * | 2000-09-18 | 2012-01-18 | 株式会社東洋発酵 | 肝障害低減剤 |
| KR100661032B1 (ko) * | 2005-04-19 | 2006-12-22 | 주식회사한국야쿠르트 | 간 기능 개선, 혈중 알코올 감소 및 항산화에 유효한조성물 |
| CN101731630B (zh) * | 2010-01-22 | 2012-10-10 | 完美（中国）有限公司 | 一种具有解酒、护肝功效的保健食品 |
| FI127823B (en) * | 2015-03-06 | 2019-03-15 | Biohit Oyj | Composition for preventing hangover symptoms |
| KR101853603B1 (ko) * | 2017-05-18 | 2018-05-02 | 주식회사 쎌바이오텍 | 알코올 또는 아세트알데하이드 분해용 프로바이오틱스를 포함하는 조성물 |
| KR20190091053A (ko) * | 2018-01-26 | 2019-08-05 | 주식회사 케이엠에프 | 아미노산 강화분말을 유효성분으로 포함하는 숙취개선용 조성물 및 그 제조방법 |
-
2022
- 2022-03-31 GB GB2204716.1A patent/GB2617183B/en active Active
-
2023
- 2023-03-30 CN CN202380039669.9A patent/CN119343134A/zh active Pending
- 2023-03-30 CA CA3246845A patent/CA3246845A1/en active Pending
- 2023-03-30 WO PCT/EP2023/058370 patent/WO2023187097A1/en not_active Ceased
- 2023-03-30 JP JP2024557929A patent/JP2025511131A/ja active Pending
- 2023-03-30 US US18/851,739 patent/US20250213626A1/en active Pending
- 2023-03-30 AU AU2023246874A patent/AU2023246874A1/en active Pending
- 2023-03-30 EP EP23717428.9A patent/EP4499048A1/en active Pending
- 2023-03-30 KR KR1020247035468A patent/KR20240167863A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6908332B2 (ja) | 病原性細菌生育の抑制のための組成物および方法 | |
| US11793841B2 (en) | Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome | |
| Li et al. | Saccharomyces boulardii alleviates DSS-induced intestinal barrier dysfunction and inflammation in humanized mice | |
| EP2040724B1 (en) | Biotherapeutic compositions comprising probiotic escherichia coli and metronidazole and uses thereof | |
| JP2019520340A5 (https=) | ||
| JP2024099590A5 (https=) | ||
| CA3093380A1 (en) | Compositions for use in balancing microbiome | |
| RU2005134223A (ru) | Композиции, содержащие штаммы lactobacillus plantarum в сочетании с танином и новые штаммы lactobacillus plantarum | |
| CN114470010B (zh) | 乳双歧杆菌bl-11的新用途 | |
| EA021890B1 (ru) | Способ предотвращения и/или лечения болезни воспаленного кишечника, язвенного колита и болезни крона | |
| JP2010535767A5 (https=) | ||
| McKenney et al. | Microbiota and pathogen ‘pas de deux’: setting up and breaking down barriers to intestinal infection | |
| JP2022510780A5 (https=) | ||
| JP2025511131A5 (https=) | ||
| Navarro-López et al. | Oral intake of Kluyveromyces marxianus B0399 plus Lactobacillus rhamnosus CECT 30579 to mitigate symptoms in COVID-19 patients: A randomized open label clinical trial | |
| KR20250052330A (ko) | 장 상피 손상 질환 치료를 위한 멜라토닌과 pge2의 병용 투여용 약학 조성물 | |
| CN119464165B (zh) | 口腔链球菌zrsor-5及其相关产品、方法及应用 | |
| US20230414599A1 (en) | Nicotinamide, nicotinamide precursors and nicotinamide metabolites and compositions thereof for reducing the time to resolution of symptoms in patients with covid-19 and other viral infections | |
| Al-Judaibi | Microbiota and their Influence in the Human Body. | |
| JP5358219B2 (ja) | 腸疾患治療剤 | |
| US20070059292A1 (en) | Use of enterococcus faecium strains for curing hepatic insufficiency and for regenerating and intensifying metabolism in a liver | |
| EA034885B1 (ru) | Новая схема лечения тиакумициновым соединением | |
| Luo et al. | Inhaled ribavirin therapy in adult respiratory syncytial virus-induced acute respiratory distress syndrome | |
| Mahajan et al. | The significance of water-soluble vitamins in SARS and related infections | |
| CN116635025A (zh) | 用于缩短covid-19和其他病毒感染患者的症状消退时间的烟酰胺、烟酰胺前体和烟酰胺代谢物及其组合物 |